We are live on
!
Find out more
BCM
Bourgeon Capital Management Portfolio holdings
AUM
$679M
1-Year Est. Return
50.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.82%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$330M
AUM Growth
+$48.9M
(+17%)
Cap. Flow
+$31.4M
Cap. Flow
% of AUM
9.51%
Top 10 Holdings %
Top 10 Hldgs %
32.98%
Holding
327
New
68
Increased
65
Reduced
43
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$7.96M |
| 2 |
First Solar
FSLR
|
+$6.74M |
| 3 |
Phillips 66
PSX
|
+$6.3M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$4.56M |
| 5 |
Gilead Sciences
GILD
|
+$4.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$7.17M |
| 2 |
Becton Dickinson
BDX
|
+$4.98M |
| 3 |
NVIDIA
NVDA
|
+$3.9M |
| 4 |
iShares Gold Trust
IAU
|
+$3.25M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$940K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.08% |
| 2 | Healthcare | 17.45% |
| 3 | Industrials | 15.82% |
| 4 | Financials | 11.35% |
| 5 | Energy | 7.15% |
Similar funds
AP
MCO
HI
REAM
CCG
DLIC
TWM
CIA
Bourgeon Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Bourgeon Capital Management held 327 positions worth $330M, up 17% from $281M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bourgeon Capital Management deployed $31.4M of net new capital in Q3 2020, opening 68 new positions and adding to 65 existing holdings. Its largest new stake was Medtronic: 79,295 shares worth $8.24M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $7.17M trimmed.
- Bourgeon Capital Management's largest Q3 2020 buy was Medtronic: 79,295 shares worth $8.24M.
- Bourgeon Capital Management added most to First Solar in Q3 2020, an estimated $6.74M increase.
- Bourgeon Capital Management's biggest Q3 2020 reduction was Weyerhaeuser, cutting an estimated $7.17M.
- Bourgeon Capital Management fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $154K.
- Bourgeon Capital Management's ten largest holdings make up 33% of its $330M portfolio in Q3 2020.
- Bourgeon Capital Management opened 68 new positions and closed 21 in Q3 2020.
- Bourgeon Capital Management's portfolio value rose 17% quarter-over-quarter to $330M.
Based on Bourgeon Capital Management's 13F filing for Q3 2020, filed 28 Oct 2020.